The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - Bayer
Prospective analysis of microRNA 31-3p (miR31-3p) as a predictive biomarker of response to anti-epidermal growth factor receptor (anti-EGFR) monoclonal antibodies (mABs) in patients with metastatic colorectal cancer (mCRC).
 
Gayathri Anandappa
No Relationships to Disclose
 
Andrea Lampis
No Relationships to Disclose
 
David Cunningham
Research Funding - 4SC (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Clovis Oncology (Inst); Janssen (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Merrimack (Inst); Sanofi (Inst)
 
Kyriakos Kouvelakis
No Relationships to Disclose
 
Khurum Khan
No Relationships to Disclose
 
George Vlachogiannis
No Relationships to Disclose
 
Nina Tunariu
No Relationships to Disclose
 
Sheela Rao
No Relationships to Disclose
 
David Watkins
Travel, Accommodations, Expenses - Amgen
 
Naureen Starling
No Relationships to Disclose
 
Chiara Braconi
Honoraria - Bayer (I); Lilly (I); Merck (I)
 
Clare Peckitt
No Relationships to Disclose
 
Janet Thomas
No Relationships to Disclose
 
Isma Rana
No Relationships to Disclose
 
Ruwaida Begum
No Relationships to Disclose
 
Annette Bryant
No Relationships to Disclose
 
Jens Hahne
No Relationships to Disclose
 
Ian Chau
Honoraria - Amgen; Gilead Sciences; Lilly; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Five Prime Therapeutics; Lilly; MSD Oncology; Roche/Genentech; Sanofi
Research Funding - Janssen-Cilag (Inst); Lilly (Inst); Merck Serono (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; Merck Serono; MSD; Sanofi
 
Matteo Fassan
No Relationships to Disclose
 
Nicola Valeri
Honoraria - Bayer; Lilly; Merck